Stem Cell Transplant: Clinical Trials

38 trials for Stem Cell Transplant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 9 recruiting, 5 unknown, 1 active not recruiting. 16 Not applicable, 9 Phase 1, 7 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 11, Recruiting 5
Phase 19Completed 5, Unknown 4
Phase 27Completed 2, Recruiting 2, Unknown 2, Withdrawn 1
Early Phase 11Recruiting 1
Phase 31Recruiting 1
Phase 41Completed 1

Follow Stem Cell Transplant: new trials by email Literature Review of Stem Cell Transplant trials Research Report on Stem Cell Transplant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Venetoclax, Hematopoietic Cell Transplantation Conditioning Regimen, Kidney Transplant - Kidney Failure Chronic, Stem Cell Transplant
Early Phase 1RecruitingMassachusetts General Hospital32026-02-042026-10-14
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Total Body Irradiation 8 Gy, Ruxolitinib, Blinatumomab - Acute Lymphoblastic Leukemia (ALL), Stem Cell Transplant
Phase 2 / Phase 3RecruitingBambino Gesù Hospital and Research Institute10002026-01-072026-10-20
Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT
Stem Cell Transplant, Late Effect
Not yet recruitingCopenhagen University Hospital, Rigshospitalet1752025-09-012025-09-04
Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
Dyadic Problem Solving Training, Supportive Care - Stem Cell Transplant, Hematopoetic Stem Cell Transplant
Not applicableRecruitingUniversity of Pittsburgh2082025-07-012026-04-01
Psychoeducation for AlloHCT Caregivers
Psychoeducation - Cancer, Caregivers
Not applicableCompletedUniversity Health Network, Toronto172025-05-212026-06-15
Mosaic Trial for Stem Cell Transplant Recipients
Intervention website, Enhanced Usual Care (Control) Website - Hematologic Malignancy, Stem Cell Transplant
Not applicableRecruitingNorthwestern University3562025-04-282026-08-03
Fertility Protection for Children, Adolescents and Young Adults
Stem Cell Transplant, Stem Cell Transplantation
RecruitingUniversity of Ulm20002024-12-092025-01-16
Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients
Peer Support - Cancer, Leukemia
Not applicableCompletedUniversity Health Network, Toronto132024-05-242026-01-06
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
Virus specific T cells - CMV Infection, EBV Infection
Phase 1 / Phase 2UnknownPeking University People's Hospital292023-11-012023-10-10
Shingrix In Recipients of Allogeneic Transplants
Zoster Vaccine Recombinant - Bone Marrow Transplant, Stem Cell Transplant
Phase 2RecruitingUniversity of Colorado, Denver552023-10-242026-10-06
BMT4me: Post-HSCT Medication Adherence mHealth App
BMT4me 2.0 app - Stem Cell Transplant, Adherence, Medication
Not applicableCompletedMicah Skeens502022-11-292026-03-30
Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma
Multiple Myeloma, Stem Cell Transplant
CompletedGruppo Italiano Trapianto di Midollo Osseo2022021-12-172023-10-05
Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.
Strength training - Stem Cell Transplant, Late Effect
Not applicableCompletedCopenhagen University Hospital, Rigshospitalet282021-09-082026-05-11
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
W8L2G mobile health (mHealth) app - Obesity, Stem Cell Transplant
Not applicableRecruitingUniversity of California, Los Angeles202021-08-152026-01-28
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients
Education - Stem Cell Transplant, CAR T-Cell Transplant
Not applicableCompletedDartmouth-Hitchcock Medical Center312021-02-072023-11-22
Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation
Pack Health's Digital Life Coaching (DLC), Electronic Handouts - Multiple Myeloma, Stem Cell Transplant
Not applicableCompletedUniversity of California, San Francisco602020-12-292023-07-20
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis
MR-MC-01 - Interstitial Cystitis, Stem Cell Transplant
Phase 1UnknownAsan Medical Center32020-10-202020-10-30
Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Comprehensive geriatric assessment (CGA) - Stem Cell Transplant
UnknownAssistance Publique - Hôpitaux de Paris2052020-07-032024-06-26
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
PiCASO Intervention Group, Sham Comparator: Attention Control Group - Sickle Cell Disease, Chronic Kidney Diseases
Not applicableCompletedDuke University2222019-10-292026-07-17
Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa
Stem cell implantation - Retinitis Pigmentosa, Stem Cell Transplant
Phase 1 / Phase 2CompletedAcibadem University152019-10-112023-02-03

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Leukemia (4)  ·  Multiple Myeloma (4)  ·  Neoplasms (4)  ·  Hematologic Neoplasms (3)  ·  Cytomegalovirus Infections (2)  ·  Epstein-Barr Virus Infections (2)  ·  Lymphoma (2)  ·  Metabolic Syndrome (2)  ·  Renal Insufficiency, Chronic (2)  ·  Adenoviridae Infections (1)  ·  Anemia, Aplastic (1)  ·  Anemia, Sickle Cell (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Cardiovascular Diseases (1)

Broader conditions

Hematologic Diseases (11)  ·  Hemic and Lymphatic Diseases (11)  ·  Immune System Diseases (8)  ·  Neoplasms (8)  ·  Neoplasms by Histologic Type (7)  ·  Immunoproliferative Disorders (5)  ·  Lymphoproliferative Disorders (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Blood Protein Disorders (4)  ·  Cardiovascular Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Hemorrhagic Disorders (4)  ·  Hemostatic Disorders (4)  ·  Metabolic Diseases (4)

Interventions

1-(di-(2-pyridyl)methylene)-5-salicylidenethiocarbonohydrazide (1)  ·  Adrenal Cortex Hormones (1)  ·  Amyloid (1)  ·  Cyclophosphamide (1)  ·  Dasatinib (1)  ·  Educational Status (1)  ·  Geriatric Assessment (1)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  Kidney Transplantation (1)  ·  Massage (1)  ·  Palliative Care (1)  ·  Quercetin (1)  ·  Relaxation Therapy (1)  ·  Resistance Training (1)  ·  Sirolimus (1)

Sponsors

Duke University (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Baylor College of Medicine (2)  ·  Copenhagen University Hospital, Rigshospitalet (2)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  Massachusetts General Hospital (2)  ·  Mayo Clinic (2)  ·  University Health Network, Toronto (2)  ·  University of California, San Francisco (2)  ·  Acibadem University (1)  ·  Asan Medical Center (1)  ·  Assiut University (1)  ·  Bambino Gesù Hospital and Research Institute (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Gruppo Italiano Trapianto di Midollo Osseo (1)

Countries

United States (22)  ·  Canada (4)  ·  Denmark (3)  ·  France (3)  ·  Germany (2)  ·  Italy (2)  ·  Austria (1)  ·  China (1)  ·  Czechia (1)  ·  Finland (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Poland (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Alan H DeCherney, M.D. (2)  ·  Angel Barnes, BSN (1)  ·  Areej El-Jawahri, MD (1)  ·  Chiara Nozzoli (1)  ·  Chris Dvorak, MD (1)  ·  Christian Denzer, Prof. Dr. (1)  ·  Dr. Laveena Munshi, MD, FRCPC (1)  ·  Franco Locatelli, Professor (1)  ·  Heather May, Pharm. D., R. Ph. (1)  ·  Helen E Heslop, MD (1)  ·  Hilde H Uhlving, MD, PhD (1)  ·  Martin Wabitsch, Prof. Dr. (1)

Results publications

PMID 23783429, PMID 25986622, PMID 29555620, PMID 32105293, PMID 33593135, PMID 36476318, PMID 38181820, PMID 38280483, PMID 38953152, PMID 39706212, PMID 39908568, PMID 40243391, PMID 40387787, PMID 40549982

NIH funding

2025 (1), R00NR019115 (1), R01CA222014 (1), R01CA268004 (1), R01CA292116 (1), R01NR018379 (1)